Laboratorios Farmaceuticos ROVI SA
MAD:ROVI

Watchlist Manager
Laboratorios Farmaceuticos ROVI SA Logo
Laboratorios Farmaceuticos ROVI SA
MAD:ROVI
Watchlist
Price: 63 EUR 1.86% Market Closed
Market Cap: 3.2B EUR
Have any thoughts about
Laboratorios Farmaceuticos ROVI SA?
Write Note

Income Statement

Earnings Waterfall
Laboratorios Farmaceuticos ROVI SA

Revenue
1B EUR
Cost of Revenue
-379.2m EUR
Gross Profit
634.1m EUR
Operating Expenses
-352.4m EUR
Operating Income
281.7m EUR
Other Expenses
-64.5m EUR
Net Income
217.2m EUR

Income Statement
Laboratorios Farmaceuticos ROVI SA

Rotate your device to view
Income Statement
Currency: EUR
Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Revenue
Revenue
230
N/A
238
+4%
241
+1%
243
+1%
242
0%
246
+1%
246
0%
254
+3%
260
+2%
265
+2%
272
+3%
275
+1%
277
+1%
276
-1%
284
+3%
283
0%
291
+3%
303
+4%
382
+26%
489
+28%
510
+4%
381
-25%
576
+51%
589
+2%
607
+3%
420
-31%
662
+58%
760
+15%
823
+8%
649
-21%
1 028
+58%
1 118
+9%
1 140
+2%
818
-28%
1 214
+49%
1 215
+0%
1 234
+2%
830
-33%
1 195
+44%
992
-17%
1 013
+2%
Gross Profit
Cost of Revenue
(93)
(95)
(96)
(96)
(94)
(97)
(96)
(102)
(110)
(112)
(116)
(116)
(114)
(108)
(108)
(109)
(110)
(129)
(159)
(206)
(217)
(167)
(251)
(254)
(264)
(179)
(288)
(344)
(358)
(264)
(406)
(424)
(441)
(298)
(452)
(461)
(461)
(337)
(480)
(385)
(379)
Gross Profit
137
N/A
143
+5%
145
+1%
147
+1%
149
+1%
149
+0%
150
+0%
151
+1%
150
-1%
153
+2%
156
+2%
159
+2%
163
+2%
168
+3%
176
+5%
174
-1%
182
+4%
175
-4%
223
+28%
284
+27%
293
+3%
215
-27%
324
+51%
335
+3%
343
+2%
241
-30%
374
+55%
416
+11%
465
+12%
385
-17%
622
+62%
694
+12%
699
+1%
520
-26%
762
+47%
754
-1%
773
+3%
492
-36%
714
+45%
607
-15%
634
+4%
Operating Income
Operating Expenses
(110)
(116)
(117)
(122)
(126)
(127)
(125)
(124)
(123)
(125)
(131)
(132)
(139)
(149)
(157)
(166)
(164)
(157)
(196)
(239)
(241)
(172)
(250)
(242)
(244)
(163)
(243)
(255)
(267)
(202)
(310)
(343)
(355)
(264)
(393)
(404)
(407)
(272)
(406)
(347)
(352)
Selling, General & Administrative
(58)
(79)
(59)
(61)
(61)
(87)
(62)
(62)
(61)
(81)
(61)
(62)
(62)
(78)
(66)
(68)
(69)
(86)
(83)
(98)
(99)
(89)
(101)
(100)
(101)
(84)
(105)
(113)
(115)
(101)
(127)
(134)
(139)
(126)
(152)
(160)
(165)
(143)
(177)
(156)
(157)
Research & Development
0
0
0
0
0
0
0
0
0
0
0
0
0
(28)
0
0
0
(32)
0
(15)
0
(29)
0
(25)
0
(24)
0
(12)
0
(27)
0
(26)
0
(24)
0
(24)
0
(25)
0
0
0
Depreciation & Amortization
(8)
(9)
(9)
(10)
(10)
(10)
(10)
(10)
(11)
(11)
(11)
(12)
(12)
(11)
(12)
(12)
(12)
(12)
(16)
(22)
(24)
(18)
(28)
(29)
(29)
(20)
(30)
(31)
(32)
(21)
(33)
(33)
(33)
(23)
(34)
(35)
(35)
(24)
(37)
(32)
(33)
Other Operating Expenses
(43)
(28)
(48)
(51)
(55)
(30)
(52)
(52)
(51)
(33)
(59)
(59)
(65)
(30)
(79)
(85)
(83)
(27)
(96)
(104)
(118)
(35)
(121)
(88)
(115)
(35)
(109)
(100)
(121)
(52)
(150)
(150)
(183)
(91)
(206)
(185)
(207)
(80)
(192)
(160)
(162)
Operating Income
27
N/A
27
+0%
28
+1%
25
-8%
23
-9%
22
-5%
25
+15%
27
+7%
27
+0%
28
+5%
25
-11%
27
+6%
24
-11%
19
-20%
19
0%
8
-55%
18
+108%
17
-1%
27
+56%
45
+64%
52
+15%
43
-16%
75
+73%
92
+24%
98
+7%
79
-20%
131
+66%
161
+23%
198
+23%
183
-8%
312
+70%
351
+13%
344
-2%
256
-26%
370
+44%
350
-5%
366
+5%
220
-40%
308
+40%
260
-16%
282
+8%
Pre-Tax Income
Interest Income Expense
(2)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(0)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(2)
(2)
(1)
(1)
(1)
1
(1)
(1)
(2)
1
(1)
0
1
(1)
(0)
(1)
(1)
Non-Reccuring Items
0
(0)
0
0
0
0
0
0
0
(0)
0
0
0
0
0
0
0
(0)
(0)
0
1
(0)
1
(1)
(3)
(4)
(6)
(6)
(4)
(2)
2
3
4
(0)
3
2
1
0
(0)
(0)
(0)
Total Other Income
(0)
0
(0)
(2)
(2)
1
0
0
0
0
0
0
(1)
(0)
0
(0)
0
0
0
0
0
(0)
0
0
0
(0)
0
0
0
(0)
0
0
0
2
0
0
(0)
1
0
0
0
Pre-Tax Income
26
N/A
26
0%
26
+3%
24
-8%
22
-8%
21
-6%
24
+15%
26
+7%
26
+1%
28
+6%
25
-11%
26
+4%
23
-13%
18
-22%
18
+0%
7
-58%
17
+126%
17
+1%
26
+59%
44
+66%
51
+17%
42
-18%
74
+77%
89
+21%
94
+5%
73
-23%
123
+70%
155
+25%
194
+25%
183
-6%
312
+71%
353
+13%
346
-2%
258
-25%
372
+44%
352
-5%
368
+4%
220
-40%
308
+40%
259
-16%
280
+8%
Net Income
Tax Provision
(2)
(2)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(2)
(2)
(1)
(0)
0
2
(1)
1
(0)
(2)
(3)
(3)
(6)
(8)
(10)
(12)
(21)
(31)
(39)
(30)
(58)
(70)
(69)
(58)
(84)
(78)
(83)
(50)
(70)
(59)
(63)
Income from Continuing Operations
24
24
25
23
21
20
23
24
25
26
23
24
22
17
18
9
16
18
26
42
48
39
68
81
84
61
102
124
154
153
254
284
277
200
288
274
285
170
237
200
217
Income to Minority Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
(0)
(0)
0
0
0
0
Net Income (Common)
24
N/A
24
0%
25
+2%
23
-8%
21
-9%
20
-5%
23
+15%
24
+6%
25
+2%
26
+5%
23
-12%
24
+3%
22
-9%
17
-20%
18
+3%
9
-49%
16
+76%
18
+13%
26
+46%
42
+59%
48
+15%
39
-18%
68
+72%
81
+20%
84
+3%
61
-27%
102
+67%
124
+21%
154
+25%
153
-1%
254
+66%
284
+12%
277
-2%
200
-28%
288
+44%
274
-5%
285
+4%
170
-40%
237
+39%
200
-16%
217
+8%
EPS (Diluted)
0.49
N/A
0.48
-2%
0.5
+4%
0.46
-8%
0.42
-9%
0.4
-5%
0.46
+15%
0.5
+9%
0.51
+2%
0.53
+4%
0.47
-11%
0.48
+2%
0.44
-8%
0.35
-20%
0.36
+3%
0.18
-50%
0.31
+72%
0.35
+13%
0.47
+34%
0.75
+60%
0.87
+16%
0.71
-18%
1.23
+73%
1.47
+20%
1.52
+3%
1.1
-28%
1.84
+67%
2.23
+21%
2.78
+25%
2.76
-1%
4.58
+66%
5.29
+16%
5.91
+12%
3.73
-37%
5.39
+45%
5.13
-5%
5.35
+4%
3.2
-40%
4.58
+43%
3.93
-14%
4.19
+7%

See Also

Discover More